ORYZON Announces a New Financing Through a Convertible Bond Program For a Total Amount of Up To 45 Million - EIN News
ORY Stock | EUR 1.48 0.02 1.33% |
About 62% of Oryzon Genomics' investor base is looking to short. The analysis of current outlook of investing in Oryzon Genomics SA suggests that many traders are alarmed regarding Oryzon Genomics' prospects. The current market sentiment, together with Oryzon Genomics' historical and current headlines, can help investors time the market. In addition, many technical investors use Oryzon Genomics SA stock news signals to limit their universe of possible portfolio assets.
Oryzon |
ORYZON Announces a New Financing Through a Convertible Bond Program For a Total Amount of Up To 45 Million EIN News
Read at news.google.com
Oryzon Genomics Fundamental Analysis
We analyze Oryzon Genomics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oryzon Genomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oryzon Genomics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Oryzon Genomics is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Oryzon Genomics SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oryzon Genomics stock to make a market-neutral strategy. Peer analysis of Oryzon Genomics could also be used in its relative valuation, which is a method of valuing Oryzon Genomics by comparing valuation metrics with similar companies.
Peers
Oryzon Genomics Related Equities
BKT | Bankinter | 1.72 | ||||
KOM | Plasticos Compuestos | 0.00 | ||||
EBRO | Ebro Foods | 0.38 | ||||
NHH | NH Hoteles | 0.48 | ||||
HOME | Neinor Homes | 0.59 | ||||
IAG | International Consolidated | 0.83 | ||||
CLNX | Cellnex Telecom | 1.31 |
Complementary Tools for Oryzon Stock analysis
When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |